Method of in vitro preconditioning healthy donor's myoblasts bef

Details Method of in vitro preconditioning healthy donor's myoblasts bef Method of in vitro preconditioning healthy donor's myoblasts bef

1995-03-16

1998-11-10

Witz, Jean C.

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Animal or plant cell

435366, 435377, C12N 506

Patent

active

058339787

ABSTRACT:
A method of pretreating healthy donor's myoblast cultures with growth or trophic factors like basic fibroblast growth factor (bFGF) on transplantation to subjects suffering of recessive myopathy like muscular dystrophy is disclosed and claimed. Recipient muscles show a higher percentage of functional cells, demonstrated by the higher incidence of dystrophin-positive fibers, and does not require previous preconditioning of recipient muscles by irradiation or toxin administration. Donor mouse myoblasts expressing the reporter gene .beta.- galactosidase were grown with 100 ng/ml bFGF during the last two days before injecting them in the left tibialis anterior (TA) muscles of recipient MHC-compatible mdx mice, an experimental animal model of muscular dystrophy. Myoblasts from the same primary cultures were also grown without bFGF and injected in the right TA muscles as control. The recipient mice were immunosuppressed with FK 506. Twenty-eight days after myoblast transplantation, the percentage of .beta.- galactosidase-positive fibers was significantly higher (more than a 4 fold increase) following culture with bFGF than without bFGF. Almost all .beta.-galactosidase-positive-fibers were also dystrophin positive.

REFERENCES:
patent: 5130141 (1992-07-01), Law et al.
patent: 5324656 (1994-06-01), Han et al.
patent: 5435999 (1995-07-01), Austin
Kinoshita et al., Muscle and Nerve 18(8): 834-841 (Aug. 1995).
Wakeford S, et al. (1991). Muscle and Nerve. 14: 42-50.
Tremblay JP et al. (1993). Cell Transplantation. 2: 99-112.
Vaidya, TB et al. (1989). Molecular Cellular Biol. 9(8): 3576-3579.
Vilquin et al. (1994). Transpl. Proc. 26(6): 3372-3373.
Sugita H, et al. (1988). Proc. Japan Acad. 64: 37-39.
Tienari, J et al. (1994). Int. J. Cancer. 56: 219-223.
Tremblay, JP et al. (1993). Neuromusc. Disord. 3(5/6): 583-592.
Partridge TA (1991). Muscle and Nerve. 14: 197-212.
Partridge TA, et al. (1989). Nature. 337: 176-179.
Patte C and Blanquet PR (1992). Cell. Mol. Biol. 38: 429-436.
Lowe et al. (1993). Endocrinology. 132: 1593-1602.
Morgan JE (1994). Human Gene Therapy. 5: 165-173.
Morgan JE et al. (1993). J. Neurol. Sci. 115: 191-200.
Koenig M et al. (1987). Cell. 50: 509-517.
Labrecque C et al. (1992). Transplant. Proc. 24(6): 2889-2892.
Law PK et al. (1990). Lancet. 336: 114-115.
Karpati G et al. (1989). Am. J. Pathol. 135: 27-32.
Kinoshita I et al. (1994). Muscle and Nerve. 17: 975-980.
Kinoshita I et al. (1994). Muscle and Nerve. 17: 1407-1415.
Huard J et al. (1992). Muscle and Nerve. 15: 550-560.
Huard J et al. (1994). 93: J. Clin. Invest. 586-599.
Karpati G et al. (1993). Ann. Neurol. 34 (1): 8-17.
Hoffman EP et al. (1987). Cell. 51: 919-928.
Hsu H-Y et al. (1994). J. Biol. Chem. 269(12): 9213-9220.
Huard J et al. (1994). Muscle and Nerve. Suppl. 1: S260.
Grounds MD (1991). Path. Res. Pract. 187: 1-22.
Gussoni E, et al. (1992). Nature. 356: 435-438.
Hallauer SM et al. (1993). Development. 119: 691-701.
DiMario J, et al. (1989). Science. 244: 688-690.
DiMario J and Strohman RC (1988). Differentiation. 39: 42-49.
Florini, JR and Magri KA (1989). Am. J. Physiol. 256: C701-711.
Chen M, et al. (1992). Cell Transpl. 1: 17-22.
Clarke MSF, et al. (1993). J. Cell Sci. 106: 121-133.
Clegg CH, et al. (1987). J. Cell Biol. 105: 949-956.
Beauchamp, JR, et al. (1994). Muscle and Nerve Supp. 1: S261.
Bischoff R (1986). Dev. Biol. 115: 140-147.
Chen G and Quinn LS. (1992). J. Cell. Physiol. 153: 563-574.
Arahata K, et al. (1988). Nature. 333: 861-863.
Austin L, et al. (1992). J. Neurol. Sci. 112: 185-191.
Austin L and Burgess AW. (1991). J. Neurol. Sci. 101: 193-197.
Allen RE and Boxhorn AL. (1989). J. Cell. Physiol. 138: 311-315.
Anderson JE, et al. (1993). Growth Factor 9: 107-121.
Anderson JE, et al. (1991). Develop. Biol. 147: 96-109.
Second International Congress of the Cell Transplant Society, Minneapolis, Minn., USA, May 1-4, 1994, transplantation proceedings 26(6) . 1994. 3518, XP000572288.

Affiliated with

Also associated with

Rating

Method of in vitro preconditioning healthy donor's myoblasts bef does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of in vitro preconditioning healthy donor's myoblasts bef, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of in vitro preconditioning healthy donor's myoblasts bef will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1513879